The role of autoimmunologists in investigating and treating autoimmune disorders
- PMID: 20887816
- DOI: 10.1016/j.autrev.2010.09.020
The role of autoimmunologists in investigating and treating autoimmune disorders
Abstract
The role of an autoimmunologist is to investigate and cultivate knowledge of normal and abnormal immune responses against self, which includes developing practical know-how to manipulate autoimmune activity and direct positive autoimmune outcomes. Where a subject develops an abnormal immune response directed against normal self, resulting in an autoimmune disease, the specialist should be able to diagnose the problem and institute an appropriate treatment. Obversely, where a subject lacks an immune response against cells bearing antigens that are abnormal or not quite self, i.e., cancer cells, the specialist should ideally be able to institute a specific cancer cell killing regimen. Essentially there are two beneficial and two harmful aspects of autoimmunity autoimmunologists should be familiar with. The beneficial aspects are the immune responses that assist in the clearance of cellular breakdown products and the elimination of cancer cells. The harmful aspects consist of immune responses, or lack thereof, that manifest in autoimmune disorders, i.e., autoimmune diseases and cancer. Recent medical discoveries, especially the modified vaccination technique developed by the Barabas research group, show great promise in both preventing and curing autoimmune disorders by utilizing the immune system's natural abilities to re-establish normal health.
Copyright © 2010 Elsevier B.V. All rights reserved.
Similar articles
-
Correcting autoimmune anomalies in autoimmune disorders by immunological means, employing the modified vaccination technique.Autoimmun Rev. 2009 Jun;8(7):552-7. doi: 10.1016/j.autrev.2009.01.014. Epub 2009 Feb 3. Autoimmun Rev. 2009. PMID: 19393215 Review.
-
Modified vaccination technique for prophylactic and therapeutic applications to combat endogenous antigen-induced disorders.Scand J Immunol. 2010 Mar;71(3):125-33. doi: 10.1111/j.1365-3083.2009.02360.x. Scand J Immunol. 2010. PMID: 20415778 Review.
-
New vaccination technology for endogenous antigen-derived ailments.IDrugs. 2008 Feb;11(2):111-5. IDrugs. 2008. PMID: 18240096 Review.
-
A modified vaccination technique for the prevention and treatment of an experimental autoimmune kidney disease.Ann N Y Acad Sci. 2007 Sep;1110:619-29. doi: 10.1196/annals.1423.065. Ann N Y Acad Sci. 2007. PMID: 17911477
-
Harnessing self-reactivity in cancer immunotherapy.Semin Immunol. 1996 Oct;8(5):303-9. doi: 10.1006/smim.1996.0039. Semin Immunol. 1996. PMID: 8956459 Review.
Cited by
-
Regaining tolerance to a self-antigen by the modified vaccination technique.Clin Rev Allergy Immunol. 2013 Oct;45(2):193-201. doi: 10.1007/s12016-012-8350-y. Clin Rev Allergy Immunol. 2013. PMID: 23296949 Review.
-
Case report: anti-fibrillarin autoantibodies induced by viral molecular mimicry in a paediatric patient.Ital J Pediatr. 2025 Jul 3;51(1):208. doi: 10.1186/s13052-025-02029-0. Ital J Pediatr. 2025. PMID: 40611140 Free PMC article.
-
Detecting multiple autoantibodies to diagnose autoimmune co-morbidity (multiple autoimmune syndromes and overlap syndromes): a challenge for the autoimmunologist.Immunol Res. 2013 Jul;56(2-3):425-31. doi: 10.1007/s12026-013-8418-7. Immunol Res. 2013. PMID: 23606120 Review.
-
The clinical and the laboratory autoimmunologist: Where do we stand?Auto Immun Highlights. 2020 Jul 7;11(1):10. doi: 10.1186/s13317-020-00133-1. eCollection 2020 Dec. Auto Immun Highlights. 2020. PMID: 32670534 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical